PATENT CLAIM ANALYSIS

Application Number: 16033432
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "278000"]

Abstract:
Described herein are methods of treating non-metastatic castrate-resistant prostate cancer with anti-androgens.

Claim (Index 24):
The method of  claim 21 , wherein said method further comprises administering a gonadotropin releasing hormone (GnRH) agonist.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 95.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15851444', '15975449', '15262522', '14406520', '14151106']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8689477665177722
- 35 USC 102 Novelty (BERT): 0.6191036386500693
- Combined Prediction Score: 0.8439633537310018
- Mean Citation Score: 603.86876
- Max Citation Score: 794.75214
- Similarity Product: 489.82316592068906

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test